Heme Oxygenase, Inflammation, and Fibrosis: The Good, the Bad, and the Ugly?
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Upon injury, prolonged inflammation and oxidative stress may cause pathological wound healing and fibrosis, leading to formation of excessive scar tissue. Fibrogenesis can occur in most organs and tissues and may ultimately lead to organ dysfunction and failure. The underlying mechanisms of pathological wound healing still remain unclear, and are considered to be multifactorial, but so far, no efficient anti-fibrotic therapies exist. Extra- and intracellular levels of free heme may be increased in a variety of pathological conditions due to release from hemoproteins. Free heme possesses pro-inflammatory and oxidative properties, and may act as a danger signal. Effects of free heme may be counteracted by heme-binding proteins or by heme degradation. Heme is degraded by heme oxygenase (HO) that exists as two isoforms: inducible HO-1 and constitutively expressed HO-2. HO generates the effector molecules biliverdin/bilirubin, carbon monoxide, and free iron/ferritin. HO deficiency in mouse and man leads to exaggerated inflammation following mild insults, and accumulating epidemiological and preclinical studies support the widely recognized notion of the cytoprotective, anti-oxidative, and anti-inflammatory effects of the activity of the HO system and its effector molecules. In this review, we address the potential effects of targeted HO-1 induction or administration of HO-effector molecules as therapeutic targets in fibrotic conditions to counteract inflammatory and oxidative insults. This is exemplified by various clinically relevant conditions, such as hypertrophic scarring, chronic inflammatory liver disease, chronic pancreatitis, and chronic graft rejection in transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors affecting wound healing
Guo, S., & DiPietro, L. A. (2010) · Journal of Dental Research · doi:10.1177/0022034509359125 · Cited by 5,792
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Pathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase.
Tenhunen, R., Marver, H. S., & Schmid, R. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.61.2.748 · Cited by 1,803
Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications
Maines, M. D. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.10.3290025 · Cited by 1,707 · cited 2×
“THE HEME–HO SYSTEM The microsomal enzyme heme oxygenase (HO) catalyzes the oxidative degradation of free heme, and generates carbon monoxide (CO), ferrous iron (Fe2+), and biliverdin (Tenhunen et al., 1968; Maines, 1988).”
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 1×
“Wound healing studies in different knockout and transgenic mouse models (Fathke et al., 2004; Duffield et al., 2005; Oakley et al., 2005; Tabibiazar et al., 2006; Saito et al., 2008; Goren et al., 2009), athymic mice (Gawronska-Kozak et al., 2006), and in vivo antisense knockdown studies (Mori et…”
Inflammatory cells during wound repair: the good, the bad and the ugly
Martin, P., & Leibovich, S. J. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.09.002 · Cited by 1,340 · cited 2×
“…overwhelming amount of data have shown that inflammatory cells emigrating from blood, such as granulocytes, macrophages, and helper T cells, provide signals that promote granulation and fibrosis, including ROS, ECM deposition, and chemokines and cytokines (reviewed in Martin and Leibovich, 2005).”
Mechanisms of Cell Protection by Heme Oxygenase-1
Gozzelino, R., Jeney, V., & Soares, M. P. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105600 · Cited by 1,241 · cited 1×
“…and anti-apoptotic as well as to reduce oxidative stress and inflammation in a multitude of different cellular and rodent models (Willis et al., 1996; Soares et al., 1998; Brouard et al., 2000; Rucker et al., 2001; Wagener et al., 2003a, 2010; Ryter and Choi, 2009; Gozzelino et al., 2010).”
Pharmacological and Clinical Aspects of Heme Oxygenase
Abraham, N. G., & Kappas, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07104 · Cited by 1,115 · cited 4×
“These effects are mediated through the actions of the effector molecules generated by HO activity (Abraham and Kappas, 2008), as biliverdin and bilirubin possess strong anti-oxidant properties and CO is implicated in different signaling cascades and vasodilatation (Siow et al., 1999).”
InfluentialCarbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis
Brouard, S., Otterbein, L. E., Anrather, J., Tobiasch, E., Bach, F. H., Choi, A. M. K., & Soares, M. P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1015 · Cited by 984 · cited 1×
“…and anti-apoptotic as well as to reduce oxidative stress and inflammation in a multitude of different cellular and rodent models (Willis et al., 1996; Soares et al., 1998; Brouard et al., 2000; Rucker et al., 2001; Wagener et al., 2003a, 2010; Ryter and Choi, 2009; Gozzelino et al., 2010).”
Cited by
Krzyszczyk, P., Schloss, R., Palmer, A., & Berthiaume, F. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00419 · Cited by 1,546
Ling, K., Men, F., Wang, W.-C., Zhou, Y.-Q., Zhang, H.-W., & Ye, D.-W. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01153 · Cited by 313
Transplanting organs from pigs to humans
Sykes, M., & Sachs, D. H. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau6298 · Cited by 191
“HO-1 helps cells to protect themselves from oxidative injury through anti-inflammatory, antiapoptotic, and antiproliferative effects through mechanisms that likely involve, at least in part, the production of CO (46).”
BackgroundMitochondrial permeability transition triggers the release of mtDNA fragments
Patrushev, M., Kasymov, V., Patrusheva, V., Ushakova, T., Gogvadze, V., & Gaziev, A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4424-1 · Cited by 168
Topical application of substance P promotes wound healing in streptozotocin-induced diabetic rats
Kant, V., Kumar, D., Kumar, D., Prasad, R., Gopal, A., Pathak, N. N., Kumar, P., & Tandan, S. K. (2015) · Cytokine · doi:10.1016/j.cyto.2014.12.015 · Cited by 79
LoPresti, S. T., Popovic, B., Kulkarni, M., Skillen, C. D., & Brown, B. N. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119376 · Cited by 24
Canesin, G., Feldbrügge, L., Wei, G., Janovicova, L., Janikova, M., Csizmadia, E., Ariffin, J., Hedblom, A., Herbert, Z. T., Robson, S. C., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104983 · Cited by 19
Metadata
- Authors
- Lundvig, D. M. S., Immenschuh, S., & Wagener, F. A. D. T. G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2012
- Volume
- 3
- Pages
- 81-81
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2138275781
- Cited by
- 85
- References
- 29
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.